Masters Speciality Pharma Strengthens Capabilities in Brazil

Masters Speciality Pharma has announced the strengthening of its capabilities in Brazil through its acquisition of Masters Distribution Brazil.

The new company, located in São Caetano do Sul, São Paulo, will become part of the Master Speciality Pharma Group, and contribute to the group’s future expansion and growth plans in Latin America.

Since its incorporation eight years ago, Masters Pharmaceuticals Ltda, Brazil – the regional subsidiary of the Masters Speciality Pharma group – has focused on early-access programs through the named patient supply (NPS) of unlicensed medicines to patients and government institutions in the country. With continuing high demand and growth potential in the region, the acquisition of Masters Distribution Brazil represents an important step towards the further diversification of its business activities in the country.

Masters Distribution Brazil is already fully compliant with the local AFE (Autorizacao de Funcionamento de Empresa) and AE (Autorização Especial) regulations, which permit the registration of human medicines in all therapy classes. This enables the business to register its own products as well as manage third-party products through distributorship and licensing arrangements.

“This is an exciting acquisition for the Masters Speciality Pharma group,” said Lynda Foster, CEO of Masters Speciality Pharma.

“Masters Distribution Brazil is ideally positioned to provide importation, distribution and storage services, and to export medicinal products from Brazil to other countries. It will now become a dedicated regional hub in addition to the group’s existing distribution centres in the UK and Florida,” concluded Foster.